Table 3. Prevalence and Percentage of Antimicrobial Resistance among the Gram-Positive Isolates a.
| No. | AMP | AML | AMC | SAM | FEP | CTX | FOX | CXM | CAZ | CRO | CL | CE | CEC | CFM | IPM | MEM | VA | AK | CN | TOB | AZM | E | DO | CIP | LEV | NOR | F | FOS | DA | FD | LZD | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S. aureus | 3 | 67 | 67 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 0 | 0 | 33 | 67 | 33 | 33 | 33 | 67 | 67 | 67 | 67 | 0 | 0 | 0 | 0 |
| S. fecalis | 58 | 22 | 22 | 22 | 22 | NT | NT | NT | NT | NT | NT | NT | NT | NT | NT | NT | NT | 3 | NT | 88 | NT | NT | NT | 60 | 83 | 83 | 83 | 21 | 14 | NT | NT | 7 |
a Abbreviations: AK, Amikacin; AMP, Ampicillin; AML, Amoxicillin; AMC, Amoxicillin/clavulanic acid; AZM, Azithromycin; CAZ, Ceftazidime; CE, Cephradine; CEC, Cefaclor; CFP, Cefoperazone; CFM, Cefixime; CL, Cephalexin; CN, Gentamicin; CIP, Ciprofloxacin; CRO, Ceftriaxone; CTX, Cefotaxime; CXM, Cefuroxime; DA, Clindamycin; DO, Doxycycline; E, Erythromycin; F, Nitrofurantoin; FD, Fusidic acid; FEP, Cefepime; FOS, Fosfomycin; IPM, Imipenem; MEM, Meropenem; LEV, Levofloxacin; NOR, Norfloxacin; LZD, Linezolid; NT, Not Tested; SAM, Ampicillin/sulbactam; TOB, Tobramycin; VA, Vancomycin.